Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Abbott Rapid Diagnostics AS
AS
Active
Org 933783405
Kjelsåsveien 161, 0884
Oslo
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 1962 · 64 years old
35 employees
webshop.no.alere.com
Monitor
Share
Norway
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Abbott Rapid Diagnostics AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
918M
688M
459M
229M
0M
2021: 737M
737M
2021
2022: 563M (-24% vs 2021)
563M
-24%
2022
2023: 333M (-41% vs 2022)
333M
-41%
2023
2024: 264M (-21% vs 2023)
264M
-21%
2024
2025: 242M (-8% vs 2024)
242M
-8%
2025
EBITDA
NOK millions
98M
74M
49M
25M
0M
2021: 79M
79M
2021
2022: 50M (-37% vs 2021)
50M
-37%
2022
2023: 7M (-86% vs 2022)
7M
-86%
2023
2024: 9M (+29% vs 2023)
9M
+29%
2024
2025: 17M (+89% vs 2024)
17M
+89%
2025
Income statement
NOK thousands
Item
2025
2024
2023
2022
2021
Revenue
241 735
263 715
332 581
563 129
737 313
Staff expenses
−0
−7 398
−6 058
−5 325
−74 875
EBITDA
16 736
8 565
6 949
49 690
79 493
Depreciation & amort.
−8 714
−0
−0
−0
−3 607
EBIT
8 022
8 565
6 949
49 690
75 886
Net financials
3 221
5 906
3 751
662
1 299
Profit before tax
11 242
14 471
10 700
50 352
77 185
Tax
−0
3 235
2 376
10 855
17 319
Net profit
8 846
11 236
8 324
39 497
59 866
Balance sheet
NOK thousands
Item
2025
2024
2023
2022
2021
Total assets
179 904
146 996
238 366
311 135
310 797
Equity
143 225
134 379
214 143
205 818
166 322
Long-term debt
0
0
0
0
0
Short-term debt
36 679
12 617
24 223
105 316
144 475
Total debt
36 679
12 617
24 223
105 316
144 475
Financial ratios
5-year trend
EBITDA margin
6,9 %
This company
15,8 %
Market median
This company
Market median
56% below market
2021
2025
Equity ratio
79,6 %
This company
38,2 %
Market median
This company
Market median
108% above market
2021
2025
Return on equity
6,2 %
This company
18,4 %
Market median
This company
Market median
66% below market
2021
2025
Net profit margin
3,7 %
This company
8,1 %
Market median
This company
Market median
54% below market
2021
2025
Asset turnover
1,34×
This company
1,12×
Market median
This company
Market median
20% above market
2021
2025
Debt / equity
0,26×
This company
0,62×
Market median
This company
Market median
58% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
More on Abbott Rapid Diagnostics AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
